Adverse reactions to rivastigmine in three cases of dementia

Australian and New Zealand Journal of Psychiatry

Volumn 35, Issue 5, 2001, Pages 694-695

  Smith, David John ^a   Yukhnevich, Sergei ^a  

^a Selby Old Age Psychiatry Centre   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; OLANZAPINE; RISPERIDONE; RIVASTIGMINE; VALPROIC ACID;

AGED; AGGRESSIVENESS; AGITATION; ALZHEIMER DISEASE; AMNESIA; ANGER; BEHAVIOR DISORDER; CASE REPORT; CLINICAL PRACTICE; CONFUSION; CONTROLLED STUDY; DEMENTIA; DRUG WITHDRAWAL; FECES INCONTINENCE; FEMALE; HUMAN; IRRITABILITY; LETTER; MALE;

AGED; AGED, 80 AND OVER; AKATHISIA, DRUG-INDUCED; ALZHEIMER DISEASE; CARBAMATES; CHOLINESTERASE INHIBITORS; DEMENTIA; FEMALE; HUMANS; IRRITABLE MOOD; MALE; PHENYLCARBAMATES; TREATMENT FAILURE;

EID: 0034758392     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1614.2001.0950f.pp.x     Document Type: Letter

References (2)

1. Rivastigmine provides symptomatic benefit in dementia with Lewy bodies: Findings from a placebo-controlled international multicenter study
2. Rivastigmine provides behavioral benefits to Alzheimer's disease patients residing in a nursing home: Findings from a 26-week trial